The Global Antibiotic Research & Development Partnership (GARDP) and Institute of Science Tokyo, in Japan, have sign...
US-headquartered NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commerci...
Japan-headquartered Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately&nb...
(From Left to Right) Professor Kouichi Morita, Dean, Program Coordinator, Institute of Tropical Medicine, Nagasaki Un...
Japan's Fujitsu and Taiwan-based Acer Medical Inc., a provider of artificial intelligence (AI)-powered medical imaging a...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
Omron Healthcare, a global leader in the field of clinically proven, innovative medical equipment for home health monito...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...
Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...
Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, has officially laun...
Japan's Shimadzu Corporation has obtained premarketing notification from the US Food and Drug Administration (FDA) for i...
BioVersys AG, a multi-asset, clinical stage biopharmaceutical company based in Switzerland, focusing on research an...
AN Venture Partners (ANV), a global biotech venture capital firm, has announced the final close of its first fund, AN Ve...
The Biomedical Division of Japan-based PHC Corporation (PHCbi), a subsidiary of PHC Holdings Corporation (PHCHD), has si...
What major initiatives are lined up for Asahi's healthcare business in 2025 and beyond? Are you planning any major inves...
Japan has one of the highest life expectancies in the world, with over 28 per cent of its population being 65 years or o...
AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company deve...
